Q/C Technologies's common stock is $8.2K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
The latest common stock for QCLS is $8.2K as of June 2026. That compares with $29K in the prior-year period — down 72.1% year over year. Investors often review this figure alongside Q/C Technologies's historical trend and sector peers before judging valuation or financial health.
Over the past year, QCLS's common stock moved from $29K to $8.2K — a 72.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Q/C Technologies's operating scale or balance-sheet position.
A common stock figure of $8.2K for QCLS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting QCLS's common stock ($8.2K), review year-over-year change from $29K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Q/C Technologies's common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.